ParaMedir B.V. and their project partner (UMCG) are developing a new medical device to improve the management of AKI (acute kidney injury). Current clinically available tools are not able to continuously perform the desired measurements of multiple biomarkers that would provide the physician with real-time results. In order to recognize acute renal failure in a timely fashion, high-frequency measurements are paramount.
Within the EFRO 2018 Valorisation the main goal of the project is to develop a device that can continuously assess kidney function in an intensive care setting.
This project is supported by the province of Groningen, The Northern Netherlands Provinces Alliance (SNN), Europees Fonds voor Regionale Ontwikkeling (EFRO), and the European Union (EU).
The University Medical Center Groningen (UMCG).